Have you ever had any other type of repeated unusual spells [PhenX]   65373-3

LOINC Code


LOINC code65373-3
nameHave you ever had any other type of repeated unusual spells [PhenX]
descriptionOther than the seizure[s] you had because of a high fever, Have you ever had, or has anyone ever told you that you had, any of the following...
statusTRIAL

Fully-Specified Name

componentHave you ever had any other type of repeated unusual spells
propertyFind  =  Finding
timePt  =  Point in time:  To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements.
system^Patient
scaleOrd  =  Ordinal:  Ordered categorical responses, e.g., 1+, 2+, 3+; positive, negative; reactive, indeterminate, nonreactive.
methodPhenX

Additional Names

short nameOther repeated unusual spells PhenX

Basic Attributes

classPHENX
type2  Clinical

Associated Observations

LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations.

Member of these Panels

62763-8PhenX - epilepsy screener protocol 130401

History/Usage

first released
last updated2.65
last change typeMIN  - change to field other than name
change reasonUpdated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

Related Names

Finding
Findings
Ordinal
Other repeated unusual spells
Othr
Point in time
QL
Qual
Qualitative
Random
Screen

Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.